Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
272.57
-3.70 (-1.34%)
Sep 16, 2025, 2:05 PM EDT - Market open
Veeva Systems Market Cap
Veeva Systems has a market cap or net worth of $44.68 billion as of September 16, 2025. Its market cap has increased by 38.64% in one year.
Market Cap
44.68B
Enterprise Value
38.39B
1-Year Change
38.64%
Ranking
Category
Stock Price
$272.57
Market Cap Chart
Since October 16, 2013, Veeva Systems's market cap has increased from $4.54B to $44.68B, an increase of 883.43%. That is a compound annual growth rate of 21.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 45.28B | 32.66% |
| Dec 31, 2024 | 34.13B | 10.11% |
| Dec 29, 2023 | 31.00B | 23.38% |
| Dec 30, 2022 | 25.13B | -36.04% |
| Dec 31, 2021 | 39.28B | -4.74% |
| Dec 31, 2020 | 41.24B | 97.30% |
| Dec 31, 2019 | 20.90B | 61.04% |
| Dec 31, 2018 | 12.98B | 66.10% |
| Dec 29, 2017 | 7.81B | 39.96% |
| Dec 30, 2016 | 5.58B | 45.50% |
| Dec 31, 2015 | 3.84B | 11.25% |
| Dec 31, 2014 | 3.45B | -13.77% |
| Dec 31, 2013 | 4.00B | -11.95% |
| Oct 16, 2013 | 4.54B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |